SERVICESLeading Pharmaceutical Exporter

Recent shifts in the pharmaceutical industry model have prompted leaders to invest in innovative marketing strategies. However, many of these New Commercial Models (NCMs) have proven unsuccessful. The decline of the traditional sales consultant-to-doctor model poses challenges for pharmaceutical export sales tactics. In response to the rapidly changing industry landscape, organizations are realizing that conventional sales methods are no longer effective. Instead of introducing entirely new strategies, many companies are adapting their existing systems to meet the demands of evolving markets.

Adopting a customer-centric culture is crucial for success. Companies like Healing Pharma have embraced a customer-centric approach, analyzing the value provided to each major consumer category to thrive in challenging environments. Efforts should be made to establish unique forms of customer connection for each consumer group throughout the supply chain, whether they are practicing physicians, direct patients, or channel partners. This involves consolidating field forces, enhancing sales force engagements, leveraging digital marketing, strengthening market channels, and organizing patient education programs. Companies should not only focus on selling products but also position themselves as health prevention and management organizations.

A robust portfolio is a key foundation for success, and Healing Pharma LLC, registered in Delaware, USA, has achieved this through strategic investments in manufacturing, research, development, and mergers. When comparing product portfolios with other competitors, many fall short on innovative financing options for intangibles.

In this competitive landscape, licensing property rights across multiple markets proves essential for enhanced profitability. Some companies face financial constraints preventing them from filing medication registration applications in target countries, especially considering the exorbitant registration costs in regions like the United States, Canada, Australia, and Europe, which can be 50 to 200 times higher than in developing nations.

Achieving industry growth and survival requires timely significant actions and access to top skills at lower costs. The lack of connections between governmental institutions, academia, and industry hinders formal initiatives to decrease innovation potential. To foster industry growth, establishing a larger skilled workforce is essential. The scarcity of skilled workers in various areas, such as researchers, production personnel, regulatory affairs, foreign business development personnel, and pharmaceutical lawyers, contributes to increased costs.

While some countries benefit from a combination of dedicated talents and low expenses, the pharmaceutical industry faces challenges in globalization, lacking competence in fictionalization, facilities management, operation, copyright creation, legal acumen, global market understanding, expertise in handling multinational executives, and knowledge of international regulatory affairs.

Healing Pharma India Pvt. Ltd. certified by WHO and GMP, is a leader in third-party manufacturing for clients worldwide. Additionally, certifications from Pharmexcil and MACCIA enhance transparency in the brand’s operations and services within and outside the organization, establishing it as a reputable player in the industry.